MedPath

Impact of Protect Your Colon™ on CRC Screening

Not Applicable
Recruiting
Conditions
Colorectal Cancer Screening
Registration Number
NCT05929820
Lead Sponsor
Cedars-Sinai Medical Center
Brief Summary

The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that accurately matches patients' values and increase CRC screening uptake. To test this hypothesis, the investigators will conduct a pilot randomized controlled trial (RCT) to assess if provision of Protect Your Colon™ improves communication on CRC screening, intent to complete screening, and ultimately uptake of screening vs. usual care.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
184
Inclusion Criteria
  • Individuals 45 to 75 years old
  • No prior CRC screening or not up-to-date with CRC screening
  • Not at high risk for CRC (e.g., inflammatory bowel disease, colon polyposis syndromes, family history of CRC)
Exclusion Criteria
  • Does not speak English
  • Does not have internet access
  • Any records flagged "break the glass" or "research opt out."

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rate of completion of a CRC screening test6 months post visit

Uptake of CRC screening within 6 months of patients' initial visit

Secondary Outcome Measures
NameTimeMethod
Qualitative feedback on details of CRC screening test1 day post visit

Completion of questionnaire that looks at:

* Whether CRC screening discussions took place during the visit

* What specific CRC screening tests were discussed during the visit

* Patient's intent to complete CRC screening

* Patient's perceptions on feeling informed about the alternatives, benefits, and risks of the different screening options as well as their clarity on their personal values

* Patient's assessment of shared decision making on CRC screening

* Intervention patients' assessment of the usefulness of Protect Your Colon™

Trial Locations

Locations (1)

Cedars-Sinai Medical Center

🇺🇸

Los Angeles, California, United States

Cedars-Sinai Medical Center
🇺🇸Los Angeles, California, United States
Antwon Chaplin, BA
Contact
310.248.6790
Antwon.Chaplin@cshs.org
Christopher V Almario, MD, MSHPM
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.